1.38
                                            Schlusskurs vom Vortag:
              $1.43
            Offen:
              $1.41
            24-Stunden-Volumen:
                304.46K
            Relative Volume:
              1.67
            Marktkapitalisierung:
                $43.05M
            Einnahmen:
              $81,000
            Nettoeinkommen (Verlust:
              $-41.04M
            KGV:
              -1.0479
            EPS:
                -1.3169
            Netto-Cashflow:
                $-30.69M
            1W Leistung:
              -9.80%
            1M Leistung:
              -12.66%
            6M Leistung:
                -10.97%
            1J Leistung:
              -19.30%
            Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Firmenname
                  
                      Actinium Pharmaceuticals Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      646-767-3870
                    
                Adresse
                  
                      275 Madison Avenue, 7th Floor, New York, NY
                    
                Vergleichen Sie ATNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ATNM
                            
                             
                        Actinium Pharmaceuticals Inc 
                           | 
                    1.38 | 44.61M | 81,000 | -41.04M | -30.69M | -1.3169 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2024-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral | 
| 2024-05-14 | Eingeleitet | Stephens | Overweight | 
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy | 
| 2023-02-21 | Herabstufung | William Blair | Outperform → Mkt Perform | 
| 2022-09-08 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2022-08-25 | Eingeleitet | B. Riley Securities | Buy | 
| 2020-11-05 | Eingeleitet | Alliance Global Partners | Buy | 
| 2017-12-06 | Eingeleitet | B. Riley FBR, Inc. | Buy | 
| 2017-10-23 | Fortgesetzt | ROTH Capital | Buy | 
| 2017-09-14 | Eingeleitet | Maxim Group | Buy | 
| 2016-08-25 | Eingeleitet | ROTH Capital | Buy | 
| 2016-02-29 | Eingeleitet | H.C. Wainwright | Buy | 
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform | 
| 2014-10-01 | Eingeleitet | MLV & Co | Buy | 
| 2014-07-22 | Eingeleitet | Canaccord Genuity | Buy | 
                    Alle ansehen
                    
                  
                Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
What momentum shifts mean for Actinium Pharmaceuticals Inc.2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocks2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international marketsTrade Signal Summary & Verified Stock Trade Ideas - newser.com
How moving averages guide Actinium Pharmaceuticals Inc. tradingWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com
Identifying reversal signals in Actinium Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
Is Actinium Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire
Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meetingProduct Launch & Fast Entry Momentum Alerts - newser.com
Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderWeekly Volume Report & Short-Term High Return Strategies - newser.com
Can you recover from losses in Actinium Pharmaceuticals Inc.July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Is Actinium Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com
How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stockTrade Exit Summary & Low Risk High Win Rate Picks - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitors2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
Has Actinium Pharmaceuticals Inc. found a price floorIndex Update & AI Driven Stock Reports - newser.com
Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com
How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Published on: 2025-10-31 04:06:04 - newser.com
Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Actinium Pharmaceuticals, Inc. (ATNM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-10-30 03:05:03 - newser.com
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):